ATEC (Alphatec Holdings) 1-Year Share Buyback Ratio : -3.50% (As of Dec. 2024 )

View and export this data going back to 2006. Start your Free Trial

What is Alphatec Holdings 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Alphatec Holdings's current 1-Year Share Buyback Ratio was -3.50%.

ATEC's 1-Year Share Buyback Ratio is ranked worse than
53.99% of 576 companies
in the Medical Devices & Instruments industry
Industry Median: -2.55 vs ATEC: -3.50

Competitive Comparison of Alphatec Holdings's 1-Year Share Buyback Ratio

For the Medical Devices subindustry, Alphatec Holdings's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alphatec Holdings's 1-Year Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Alphatec Holdings's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Alphatec Holdings's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Alphatec Holdings 1-Year Share Buyback Ratio Calculation

Alphatec Holdings's 1-Year Share Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Dec. 2023 )	-	Shares Outstanding (EOP) (Dec. 2024 ))	/	Shares Outstanding (EOP) (Dec. 2023 )
	=	(139.245	-	144.129)	/	139.245
	=	-3.5%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alphatec Holdings (NAS:ATEC) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Alphatec Holdings 1-Year Share Buyback Ratio Related Terms

Alphatec Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alphatec Holdings Inc (NAS:ATEC) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

L1Z1:Germany L1Z1:Germany

Address

1950 Camino Vida Roble, Carlsbad, CA, USA, 92008

Website

https://www.atecspine.com

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

Executives

Scott Lish	officer: SVP, Development	C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
John Todd Koning	officer: Chief Financial Officer	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Patrick Miles	director, officer: Executive Chairman	7475 LUSK BLVD., SAN DIEGO CA 92121
David Sponsel	officer: EVP, Sales	C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
Karen K Mcginnis	director	INSIGHT ENTERPRISES INC, 1305 WEST AUTO DRIVE, TEMPE AZ 85284
Evan Bakst	director	225 CENTRAL PARK WEST, APT. 1605, NEW YORK NY 10024
David R Pelizzon	director, 10 percent owner	2850 FRONTIER DR, WARSAW IN 46582
David M Demski	director	C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Tyson Eliot Marshall	officer: GENERAL COUNSEL & CORP. SEC.	10680 TREENA STREET, SUITE 500, SAN DIEGO CA 92131
Quentin S. Blackford	director	7475 LUSK BLVD., SAN DIEGO CA 92121
Craig E Hunsaker	officer: See Remarks	C/O ALPHATEC HOLDINGS, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
David H Mowry	director	9775 TOLEDO, IRVINE CA 92618
Tullis James L L	director, 10 percent owner	100 FIRST STAMFORD PLACE, STAMFORD CT 06907
Jennifer N. Pritzker	10 percent owner	C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121